BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7421224)

  • 1. Prediction of ovulation by urinary estrogen assays.
    Adlercreutz H; Lehtinen T; Kairento AL
    J Steroid Biochem; 1980 Jan; 12():395-401. PubMed ID: 7421224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible method for the detection of ovulation and the determination of the duration of the fertile period.
    Baker TS; Jennison K; Kellie AE
    J Steroid Biochem; 1980 Jan; 12():411-5. PubMed ID: 7421226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles.
    Branch CM; Collins PO; Collins WP
    J Steroid Biochem; 1982 Feb; 16(2):345-7. PubMed ID: 7078170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.
    Wright K; Collins DC; Preedy JR
    Steroids; 1979 Oct; 34(4):445-57. PubMed ID: 229588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
    Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotrophin and steroid interrelationships during the normal menstrual cycle.
    Bell ET; Christie DW
    Steroidologia; 1970; 1(3):152-74. PubMed ID: 4940024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
    Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
    J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Composite microassays of plasma progesterone, 17alpha-OH-progestrerone, estrone, 17beta-estradiol and estriol in normal adult women. I. Assay methods and steroid patterns in normal menstrual cycle (author's transl)].
    Suginami H
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):908-23. PubMed ID: 1241848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct radioimmunoassay for estriol-16-glucuronide in urine for monitoring pregnancy and induction of ovulation.
    Haning RV; Satin KP; Lynskey MT; Levin RM; Speroff L
    Am J Obstet Gynecol; 1977 Aug; 128(7):793-802. PubMed ID: 879247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroids and the prediction of ovulation].
    Audebert AJ; Emperaire JC; Ruffie A
    Contracept Fertil Sex (Paris); 1984 Feb; 12(2):411-9. PubMed ID: 12265829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.